Page 4 - Development For Ipsen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development For Ipsen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development For Ipsen Today - Breaking & Trending Today

Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva

Published: December 23, 2022

The CRL is related to the U.S. FDA's previous request for additional information on palovarotene clinical trial data Ipsen anticipates responding to the request in the first quarter of 2023 Regulatory

Source: finanznachrichten.de

Related Topics:

France GeneralUnited StatesUnited Arab EmiratesUnited KingdomAnna GibbinsHoward MayerRachel ReiffHead Of ResearchDrug AdministrationDevelopment For IpsenIpsen PressMetabolic Drugs Advisory CommitteeGlobal Head Of Franchise CommunicationsProc Intl Clin CouncilUs Head Of Portfolio CommunicationsComplete Response LetterNew Drug ApplicationExecutive Vice PresidentRare DiseaseWith Specialty CareSponsored Leveli American Depositary ReceiptFrench AutoritDes MarchRegistration DocumentIntl Clin Council